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1. Introduction 
Osteogenesis imperfecta (01) is a heritable disorder 
affecting bone. Typically such patients have fragile 
bones and may also have blue sclerae, dentinogenesis 
imperfecta, hearing loss, thin skin, joint hypermobility, 
herniae and mitral valve prolapse [I]. The severity of 
the disorder varies considerably in different patients, 
and both dominant and recessive forms are known. 
This heterogeneity indicates that there must be dif- 
ferences in the molecular basis which thus far have 
escaped definition. In cases with more generalized 
affection of connective tissues, it has been proposed 
that 01 is caused by defects in the structure or metab- 
olism of type I collagen, the principal structural 
protein of bone, dentin and many other tissues. This 
concept is supported by studies demonstrating that 
fibroblasts from certain affected individuals synthesize 
collagen types I and III in an abnormally low I/III 
ratio [2,3] and that skin collagen in some patients is 
present in a decreased I/III ratio [4]. 
A low ratio of I/III collagen may reflect either 
reduced type I collagen synthesis or enhanced intra- 
cellular collagen degradation. To test this, we evaluated 
collagen production and intracellular collagen degra- 
dation in 9 normal individuals of varying ages and in 
16 patients with 01, including strain CRL-1262 [2]. 
Since only 01 strain CRL-1262 produced less than 
normal amounts of collagen but had normal degrada- 
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tion, we conclude that at least one form of the disease 
is associated with a decrease in collagen synthesis. 
2. Materials and methods 
2.1. Skin jib’hroblasts 
All cells were obtained from American Type Cul- 
ture Collection, Rockville, MD. The fibroblasts from 
9 normal individuals included CRL-: I 106, 1121, 
1141,1222,1187,1220,1224, 1120and 1221, 
representing donors from fetal to 84 years. Fibroblasts 
from 16 patients with 01 were studied including 
CRL-: 1298,1286, 1251, 1315,1293, 1288, 1267, 
1107,1287,1280; 1129, 1248, 1247, 1294, 1381 
and 1262, representing donors from fetal to 64 years. 
The subcultivation numbers of all cells were between 
4 and 8. The cells were cultured and subcultured 
according to routine techniques. 
2.2. Labelling of cells 
Cells at early confluence were preincubated with 
medium supplemented with ascorbic acid (60 pg/ml) 
for 16 h, rinsed twice with phosphate-buffered saline 
and incubated with 50 PCi [r4C]proline (285 mCi/ 
mmol) in 5 ml fresh medium containing 10% dialyzed 
fetal calf serum, 2 mM glutamine, penicillin (50 U/ml), 
streptomycin (SO pg/ml), ascorbic acid (60 pg/ml) 
and p-aminopropionitrile (50 pg/ml). After 8 h, 
medium and cell layer were combined, sonicated and 
processed as described below. 
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2.3. Quantitatioul of collagen production 
The ratio of collagen to total protein production 
was assessed by both the hydroxyproline content and 
susceptibility to collagenase. Hydroxyproline was 
determined by a modified [S] chemical procedure 
[6] or by ion-exchange chromatography on Dowex 50 
[7] and the amount of collagen per total protein 
synthesized was calculated [8]. Collagenase-sensitive 
material was determined using purified bacterial 
collagenase [9]. 
2.4. Quantitation of intracellular degradation of 
newly synthesized collagerz (IO,1 I] 
One half of the medium plus cell layer was 
lyophilized and hydrolyzed (6 N HCl, 1 lO”C, 24 h) 
and used to measure the total amount of [‘“Cl- 
hydroxyproline present in the culture. The other half 
was dialyzed against a 4-fold volume of 0.5 M acetic 
acid for 48 h at 4°C. The dialyzate was lyophilized 
and hydrolyzed, and dialyzable [14C]hydroxyproline 
was quantitated making appropriate corrections for 
the volume in the dialysis bag. 
3. Results 
The quantity of collagen produced by all but one 
strain of 01 fibroblasts was similar to that of the 
control cells. However, 01 cell strain CRL-1262 pro- 
duced only 60% of collagen (table 1). In a separate 
experiment we found that the apparent reduction of 
collagen synthesis in CRL-1262 cells was not due to 
production of underhydroxylated collagen. When 
collagenous proteins in medium and cell layer were 
measured with bacterial collagenase, collagen produc- 
tion was found to be decreased in medium and cell 
layer by -4O%, while the distribution of collagen 
between medium and cell layer was normal (table 2). 
We tested whether the decrease in overall collagen 
production found in CRL-I262 was due to increased 
intracellular degradation. Collagen degradation by 
control fibroblasts averaged 30 + 4% (mean 5 SEM, 
range 25-37%) was independent of donor age (fig.1) 
and similar to that found in human fetal lung fibro- 
blasts [ 111. Degradation by cells from all patients 
with 01 was in the same range (29 + 6%, fig.‘); degra- 
dation by CRL 1262 fibroblasts (fig.2, open circles) 
measured 34% and 3 1% (duplicates from two separate 
experiments). 
Table 2 
Production and distribution of collagen in medium and cell 
layer of 01 (CRL-I 262) and control (CRL-1121) fibroblasts 
-_____ 
Collagen per total protein (%) 
Hydroxyproline Collagenase 
method [7,8] method [9] 
- 
Medium 01 11.8 13.9 
control 24.1 23.6 
Cell layer 01 1.7 2.0 
control 3.3 3.4 
Medium and CI 7.8 9.0 
cell layer control 15.2 14.3 
_ 
Table 1 
Production of protein-bound hydroxyproline [5,6] by 01 and control 
skin fibroblasts 
Cell strains Protein-bound hydroxyproline (dpm) 
Total incorporated radioactivity (dpm) 
mean i SIN (range) 
9 controls 0.15 ? 0.02 (0.13 -0.20) 
15 osteogenesis irnperfccta 
all strains except CRL-1262 0.14 + 0.01 (0.12 -0.17) 
1 osteogenesis impcrfecta 
strain CRL-1262 0.86 (0.079-0.088)” 
a Mean and range of 4 scparatc measurements 
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Fig.1 Intracellular collagen degradation by skin fibroblasts 
derived from 8 normal donors of different apes, cxpresscd as 
‘/o dialyzable hydroxyprolinc per total [‘4C]hydrosyproline. 
The symbols (0, ., +) represent values from 3 diffcrcnt 
experiments. 
4. r)iscussion 
Collagen synthesis was decreased in one (CRL-1262) 
of 16 cell strains derived from patients with 01. We 
obtained similar results both by measuring peptide- 
bound hydroxyproline and collagenase-digestible 
protein. 
Intracellular collagen degradation was examined 
for the first time in human skin fibroblasts and was 
shown to be independent of donor age. Therefore, 
degradation by CRL-1262 cells, derived from a fetus, 
could be compared. As in all other 01 cells, collagen 
degradation was normal. Since CRL-1262 produced 
only half the normal amount of collagen, this suggested 
that the underlying defect in thi’s case was not due to 
a post-translational process but rather to an abnor- 
mality at the transcriptional or translational level(s). 
Since type I collagen accounts for 85-9070 of the 
total collagen in cultured fibroblasts, the 40% deficit 
in strain CRL-1262 was likely due to a decrease in 
type I collagen synthesis which is reflected by the 
decreased I/III collagen ratio [2]. The tissue fragility 
in this 01 patient [ 121 suggested that tissue levels of 
collagen were also reduced in vivo. Membranes rup- 
tured prematurely after weeks 30-32 of gestation, and 
there was a traumatic breech presentation with 
avulsion of head and one foot. All connective tissues 
were most fragile. Histologically, there was not only a 
decrease in collagen in endochondral and membranous 
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I:ig.2. Intracellular collagen degradation by cells from 
controls and 01 patients. Each point rcprcsents the mean 
value for agiven ccl1 strain, each horizontal bar the mean value 
for a group. CRL-I 262 is characterized by (3‘). 
bones but also in teeth, corneae, sclerae, ligaments 
and skin. Interestingly, the papillary layer of the 
dermis was relatively well preserved whereas the 
reticular layer was very thin. From immunofluorescent 
studies [ 131 it is known that the papillary dermis is 
rich in type 111 collagen whereas most of the reticular 
dermis is composed of type I collagen (these conc1~~- 
sions have recently been contested [ 141). Although 
biochemical studies on skin were not performed we 
believe that the discrepancy between the involvement 
of papillary and reticular layers is the pathological 
correlate of reduced type I collagen synthesis. 
Thus, CRL-1262 cells stood out from a series of 
16 patients with 01 in that they synthesized less 
collagen. Very recently, David Rowe of the University 
of Connecticut has made two similar observations 
(personal communication), a finding which may 
prove to be characteristic of a novel subclass of 
osteogenesis imperfecta. 
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